DE69129459T2 - Immunosuppressive zusammensetzungen - Google Patents

Immunosuppressive zusammensetzungen

Info

Publication number
DE69129459T2
DE69129459T2 DE69129459T DE69129459T DE69129459T2 DE 69129459 T2 DE69129459 T2 DE 69129459T2 DE 69129459 T DE69129459 T DE 69129459T DE 69129459 T DE69129459 T DE 69129459T DE 69129459 T2 DE69129459 T2 DE 69129459T2
Authority
DE
Germany
Prior art keywords
compound
suppressor cell
immunosuppressive
cell inducing
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69129459T
Other languages
English (en)
Other versions
DE69129459D1 (de
Inventor
Alison Mary Badger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anormed Inc
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Application granted granted Critical
Publication of DE69129459D1 publication Critical patent/DE69129459D1/de
Publication of DE69129459T2 publication Critical patent/DE69129459T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69129459T 1990-08-10 1991-08-07 Immunosuppressive zusammensetzungen Expired - Fee Related DE69129459T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56582690A 1990-08-10 1990-08-10
US62245290A 1990-12-05 1990-12-05
PCT/US1991/005619 WO1992002229A1 (en) 1990-08-10 1991-08-07 Immunosuppressive compositions

Publications (2)

Publication Number Publication Date
DE69129459D1 DE69129459D1 (de) 1998-06-25
DE69129459T2 true DE69129459T2 (de) 1998-10-15

Family

ID=27073977

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69129459T Expired - Fee Related DE69129459T2 (de) 1990-08-10 1991-08-07 Immunosuppressive zusammensetzungen

Country Status (12)

Country Link
EP (1) EP0542860B1 (de)
JP (1) JP2675194B2 (de)
KR (1) KR100215167B1 (de)
AT (1) ATE166228T1 (de)
AU (1) AU658577B2 (de)
CA (1) CA2088492A1 (de)
DE (1) DE69129459T2 (de)
DK (1) DK0542860T3 (de)
ES (1) ES2118087T3 (de)
GR (1) GR3027668T3 (de)
HK (1) HK1011503A1 (de)
WO (1) WO1992002229A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286731A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory bowel disease
US5286730A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
GB9217116D0 (en) * 1992-08-13 1992-09-23 Smithkline Beecham Corp Methods
GB9217121D0 (en) * 1992-08-13 1992-09-23 Smithkline Beecham Corp Methods
EP0605161A3 (de) * 1992-12-29 1994-10-05 American Home Prod Senkung des Rheumafaktorenspiegels.
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
EP0721335B1 (de) * 1993-10-01 2005-08-31 Roche Palo Alto LLC Hochdosierte oral anzuwendende suspensionen enthaltendmycophenolat mofetil
US5561138A (en) * 1994-12-13 1996-10-01 American Home Products Corporation Method of treating anemia
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
BE1009856A5 (fr) 1995-07-14 1997-10-07 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
US5843936A (en) * 1996-06-28 1998-12-01 Bernstein; Lawrence R. Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes
DE19728436A1 (de) * 1997-07-03 1999-01-07 Niels Franke Niedrigdosierte 15-Desoxyspergualin-Präparate
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes

Also Published As

Publication number Publication date
JPH06500321A (ja) 1994-01-13
DK0542860T3 (da) 1999-02-15
HK1011503A1 (en) 1999-07-09
CA2088492A1 (en) 1992-02-11
ATE166228T1 (de) 1998-06-15
EP0542860A4 (en) 1993-08-04
AU8412091A (en) 1992-03-02
EP0542860A1 (de) 1993-05-26
WO1992002229A1 (en) 1992-02-20
GR3027668T3 (en) 1998-11-30
JP2675194B2 (ja) 1997-11-12
ES2118087T3 (es) 1998-09-16
DE69129459D1 (de) 1998-06-25
KR100215167B1 (ko) 1999-08-16
AU658577B2 (en) 1995-04-27
EP0542860B1 (de) 1998-05-20

Similar Documents

Publication Publication Date Title
DK0542860T3 (da) Immunosuppressive sammensætninger
KR870005637A (ko) 약물 데포
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT951473E (pt) Novos derivados da ciclosporina sua preparacao e composicoes farmaceuticas que os contem
ATE198835T1 (de) Knochenwachstumsfördernde zusammensetzung
NL300098I2 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
DE69434121D1 (de) Pharmazeutische zusammensetzung zur immunstimulierenden therapie
CA2034484A1 (en) Radioimmunotherapy using .alpha.-particles emission
ZA967880B (en) Compositions and methods for inhibition of the patho-physiologic actions in mammals in tumor necrosis facto-alpha
DE59406938D1 (de) Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält
SE8804628D0 (sv) New compounds
FI921525A0 (fi) Amidinofenylalaninderivat, foerfarande foer deras framstaellning, deras anvaendning och dessa innehaollande aemnen.
KR860000867A (ko) 급성 방사선 증후군 발현억제 및 패혈증 발현억제의 방법 및 그 조성물
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
YU47338B (sh) Novo jedinjenje 4-fluoro-2-// (4-metoksi-2-piridinil)metil-/sulfinil/- 1h-benzimidazol i postupak za njegovo dobijanje
IT8867891A0 (it) Derivati terziobutilati di benzilidene canfora procedimento per la loro preparazione,loro impiego come agenti anti ossidanti e composizioni cosmetiche e farmaceutiche che li contengono
DE3875611D1 (de) Pharmazeutische zusammensetzungen.
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
FI924215A0 (fi) Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen.
ES2191657T3 (es) Azaspiranos inmunomoduladores.
KR910002792A (ko) 1-치환된-2-(3-아미노-1-프로피닐)피롤리딘 유도체, 그에 의한 중추 콜린성 기능 장해 치료 방법 및 그로구성되는 제약학적 조성물
MX9203732A (es) R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee